Sergej Konoplev

9.5k citations

154 papers · 4.6k indexed · h-index 35

Hematology top 0.2%
- Acute Myeloid Leukemia Research 55
- Chronic Myeloid Leukemia Treatments 22
Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research 34
- Myeloproliferative Neoplasms: Diagnosis and Treatment 18
Pathology and Forensic Medicine top 1%
- Lymphoma Diagnosis and Treatment 43
Oncology top 2%
Immunology top 2%
- Immune Cell Function and Interaction 14
Public Health, Environmental and Occupational Health
- Acute Lymphoblastic Leukemia research 21
Dermatology
- Cutaneous lymphoproliferative disorders research 16

Co-authors: L. Jeffrey Medeiros Marina Konopleva Michael Andreeff Hagop M. Kantarjian Carlos E. Bueso‐Ramos Jeffrey L. Jorgensen Pei Lin A.Yu. Zaritskey
Cited by: Hematology Genetics Pathology and Forensic Medicine
Partner nations: United States China Russia

In The Last Decade

Sergej Konoplev

146 papers receiving 4.6k citations

Peers

Countries citing papers authored by Sergej Konoplev

Since Specialization

Citations

This map shows the geographic impact of Sergej Konoplev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergej Konoplev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergej Konoplev more than expected).

Fields of papers citing papers by Sergej Konoplev

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergej Konoplev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergej Konoplev. The network helps show where Sergej Konoplev may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Sergej Konoplev, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sergej Konoplev Line = papers co-authored together Sergej Konoplev links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Prediction of survival with intensive chemotherapy in acute myeloid leukemia Koji Sasaki,Farhad Ravandi,Tapan M. Kadia,Courtney D. DiNardo,Gautam Borthakur,Nicholas J. Short,Nitin Jain,Naval Daver,Elias Jabbour,Guillermo Garcia‐Manero,Joseph D. Khoury,Sergej Konoplev,Sanam Loghavi,Keyur P. Patel,Guillermo Montalban‐Bravo,Lucia Masárová,Marina Konopleva,Hagop M. Kantarjian	2022	13
2	Improved outcomes among newly diagnosed patients with FMS‐like tyrosine kinase 3 internal tandem duplication mutated acute myeloid leukemia treated with contemporary therapy: Revisiting the European LeukemiaNet adverse risk classification Patrick K. Reville,Koji Sasaki,Hagop M. Kantarjian,Naval Daver,Musa Yılmaz,Courtney D. DiNardo,Nicholas J. Short,Gautam Borthakur,Naveen Pemmaraju,Rohtesh S. Mehta,Sherry Pierce,Sergej Konoplev,Joseph D. Khoury,Guillermo Garcia‐Manero,Marina Konopleva,Elias Jabbour,Farhad Ravandi,Tapan M. Kadia	2022	16
3	Immunohistochemical loss of enhancer of Zeste Homolog 2 (EZH2) protein expression correlates with EZH2 alterations and portends a worse outcome in myelodysplastic syndromes Ali Sakhdari,Caleb A. Class,Guillermo Montalban‐Bravo,Koji Sasaki,Carlos E. Bueso‐Ramos,Keyur P. Patel,Mark J. Routbort,Sanam Loghavi,Chi Young Ok,Andres Quesada,Joseph D. Khoury,Sergej Konoplev,Hagop P. Kantarjian,Guillermo Garcia‐Manero,L. Jeffrey Medeiros,Rashmi Kanagal‐Shamanna	2022	6
4	Small cell/lymphohistiocytic morphology is associated with peripheral blood involvement, CD8 positivity and retained T-cell antigens, but not outcome in adults with ALK+ anaplastic large cell lymphoma Mahsa Khanlari,Shaoying Li,Roberto N. Miranda,Swaminathan P. Iyer,Sergej Konoplev,Pei Lin,C. Cameron Yin,Guilin Tang,Lianqun Qiu,Francisco Vega,L. Jeffrey Medeiros,Jie Xu	2021	5
5	The Leukemic Phase of ALK-Negative Anaplastic Large Cell Lymphoma Is Associated with CD7 Positivity, Complex Karyotype, TP53 Deletion, and a Poor Prognosis Lianqun Qiu,L. Jeffrey Medeiros,Guilin Tang,Mahsa Khanlari,Shaoying Li,Sergej Konoplev,Sa A. Wang,C. Cameron Yin,Joseph D. Khoury,Wei Wang,Roberto N. Miranda,Swaminathan P. Iyer,M. James You,Jie Xu	2021	5
6	Outcome of T‐cell acute lymphoblastic leukemia/lymphoma: Focus on near‐ETP phenotype and differential impact of nelarabine Kiyomi Morita,Nitin Jain,Hagop M. Kantarjian,Koichi Takahashi,Hong Fang,Marina Konopleva,Siba El Hussein,Feng Wang,Nicholas J. Short,Abhishek Maiti,Koji Sasaki,Guillermo Garcia‐Manero,Sergej Konoplev,Farhad Ravandi,Joseph D. Khoury,Elias Jabbour	2021	54
7	MYC expression is associated with older age, common morphology, increased MYC copy number, and poorer prognosis in patients with ALK+ anaplastic large cell lymphoma Kirill A. Lyapichev,Guilin Tang,Shaoying Li,M. James You,Tingsing J. Cheng,Roberto N. Miranda,Swaminathan P. Iyer,C. Cameron Yin,Sergej Konoplev,Carlos E. Bueso‐Ramos,Francisco Vega,L. Jeffrey Medeiros,Jie Xu	2020	10
8	The efficacy of omalizumab in Cutaneous Mastocytosis: A case series Tiffany Hinojosa,Daniel J. Lewis,Ramya Vangipuram,Laraib Z. Safeer,Uyen Ngoc Mui,Christopher T. Haley,Sergej Konoplev,Stephen K. Tyring	2019	8
9	P53 protein overexpression in de novo acute myeloid leukemia patients with normal diploid karyotype correlates with FLT3 internal tandem duplication and worse relapse‐free survival Rita Assi,Hatice Gur,Sanam Loghavi,Sergej Konoplev,Marina Konopleva,Naval Daver,Mehrnoosh Tashakori,Tapan M. Kadia,Mark J. Routbort,Alireza Salem,Rashmi Kanagal‐Shamanna,Andres Quesada,Elias Jabbour,Steven M. Kornblau,L. Jeffrey Medeiros,Hagop M. Kantarjian,Joseph D. Khoury	2018	16
10	Biclonal IGHV‐4‐34 hairy cell leukemia variant and CLL ‐ successful treatment with ibrutinib and venetoclax Preetesh Jain,Rashmi Kanagal‐Shamanna,Sergej Konoplev,Zhuang Zuo,Zeev Estrov	2018	24
11	Long-Term Outcomes in Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Naveen Pemmaraju,Hagop M. Kantarjian,Joseph D. Khoury,Susan O’Brien,Jörge E. Cortes,Guillermo Garcia‐Manero,Elias Jabbour,Nitin Jain,Yesid Alvarado,Madeleine Duvic,Phyu P. Aung,Muzaffar H. Qazilbash,C. Cameron Yin,Sergej Konoplev,Keyur P. Patel,Sherry Pierce,Mark Brandt,Marina Konopleva	2017	5
12	CD123 Expression Patterns and Potential of IMGN632, a CD123-Targeted Antibody Drug Conjugate, in Acute Lymphoblastic Leukemia Evgeniya Angelova,Charlene A. Audette,Yelena Kovtun,Naval Daver,Sa A. Wang,Sherry Pierce,Sergej Konoplev,Jeffrey L. Jorgensen,Marina Konopleva,Patrick A. Zweidler‐McKay,Hagop M. Kantarjian,Elias Jabbour,Joseph D. Khoury	2017	2
13	Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy Byung-Sik Cho,Zhihong Zeng,Hong Mu,Zhiqiang Wang,Sergej Konoplev,Teresa McQueen,Marina Protopopova,Jörge E. Cortes,Joseph R. Marszalek,Sheng‐Bin Peng,Wencai Ma,R. Eric Davis,Donald Thornton,Michael Andreeff,Marina Konopleva	2015	95
14	Flow cytometry immunophenotypic findings in chronic myelomonocytic leukemia and its utility in monitoring treatment response Qi Shen,Juan Ouyang,Guilin Tang,Elias Jabbour,Guillermo Garcia‐Manero,Mark J. Routbort,Sergej Konoplev,Carlos E. Bueso‐Ramos,L. Jeffrey Medeiros,Jeffrey L. Jorgensen,Sa A. Wang	2014	24
15	A Phase I First-in-Human Trial of Bardoxolone Methyl in Patients with Advanced Solid Tumors and Lymphomas David S. Hong,Razelle Kurzrock,Jeffrey G. Supko,Xiaoying He,Aung Naing,Jennifer J. Wheler,Donald P. Lawrence,Joseph P. Eder,Colin J. Meyer,Deborah A. Ferguson,James W. Mier,Marina Konopleva,Sergej Konoplev,Michael Andreeff,Donald Küfe,Hillard Lazarus,Geoffrey I. Shapiro,Bruce J. Dezube	2012	197
16	Unusual Presentation of a Dysembryoplastic Neuroepithelial Tumor Mimicking a Pontomesencephalic Cavernous Hemangioma Daniela Hoehn,Sergej Konoplev,C. Cameron Yin	2012	2
17	Blastic Plasmacytoid Dendritic Cell Neoplasm With Leukemic Progression Choladda V. Curry,Sergej Konoplev,Carlos A. Torres‐Cabala,Amin M. Alousi,Madeleine Duvic,Jonathan L. Curry	2012	1
18	Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML Zhihong Zeng,Yue Shi,Ismael Samudio,Rui-Yu Wang,Xiaoyang Ling,Olga Frolova,Mark J. Levis,Joshua B. Rubin,Robert Negrin,Elihu H. Estey,Sergej Konoplev,Michael Andreeff,Marina Konopleva	2008	397
19	Phase I trial with a novel orally administered synthetic triterpenoid RTA 402 (CDDO-Me) in patients with solid tumors and lymphoid malignancies David S. Hong,Razelle Kurzrock,Jeffrey G. Supko,Donald P. Lawrence,Jennifer Wheeler,Joseph P. Eder,Chaan Ng,James W. Mier,Marina Konopleva,Sergej Konoplev,Sühendan Ekmekçioglu,Michael Andreeff,Elizabeth Grimm,Donald Küfe,Colin J. Meyer,Geoffrey I. Shapiro,Bruce J. Dezube	2007	4
20	HER-2/neu overexpression as a poor prognostic factor for patients with metastatic breast cancer undergoing high-dose chemotherapy with autologous stem cell transplantation. Young Sil Kim,Sergej Konoplev,Filippo Montemurro,Emma Hoy,Terry L. Smith,Gabriela Rondón,Richard Champlin,Ayşegül A. Şahin,Naoto T. Ueno	2001	33

About Sergej Konoplev

Sergej Konoplev is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine, having authored 154 papers that have together received 4.6k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (55 papers), Lymphoma Diagnosis and Treatment (43 papers), Chronic Lymphocytic Leukemia Research (34 papers), Chronic Myeloid Leukemia Treatments (22 papers), Acute Lymphoblastic Leukemia research (21 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (18 papers), Cutaneous lymphoproliferative disorders research (16 papers) and Immune Cell Function and Interaction (14 papers). The work is most often cited by research in Hematology (2.2k citations), Genetics (1.2k citations) and Pathology and Forensic Medicine (964 citations). Sergej Konoplev has collaborated with scholars based in United States, China and Russia. Frequent co-authors include L. Jeffrey Medeiros, Marina Konopleva, Michael Andreeff, Hagop M. Kantarjian, Carlos E. Bueso‐Ramos, Jeffrey L. Jorgensen, Pei Lin, A.Yu. Zaritskey, Wei Hu and C. Cameron Yin.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact